{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:42:22Z","timestamp":1790613742625,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515111168"],"award-info":[{"award-number":["2022A1515111168"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971749"],"award-info":[{"award-number":["81971749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302374"],"award-info":[{"award-number":["82302374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072064"],"award-info":[{"award-number":["82072064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303768"],"award-info":[{"award-number":["82303768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA0910001"],"award-info":[{"award-number":["2021YFA0910001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2402400"],"award-info":[{"award-number":["2022YFC2402400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA0915400"],"award-info":[{"award-number":["2023YFA0915400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA0910000"],"award-info":[{"award-number":["2021YFA0910000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013321","name":"Chinese Academy of Sciences Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324115607020"],"award-info":[{"award-number":["JCYJ20210324115607020"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109114616534"],"award-info":[{"award-number":["JCYJ20200109114616534"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324101807020"],"award-info":[{"award-number":["JCYJ20210324101807020"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010780"],"award-info":[{"award-number":["2022A1515010780"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693313"],"award-info":[{"award-number":["2021M693313"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.celrep.2024.114086","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T06:57:32Z","timestamp":1712645852000},"page":"114086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1\/IL-12 engineered probiotics"],"prefix":"10.1016","volume":"43","author":[{"given":"Jianhong","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-6390","authenticated-orcid":false,"given":"Lintao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114086_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114086_bib2","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.celrep.2024.114086_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2020.00339","article-title":"Progress and Challenges in Precise Treatment of Tumors With PD-1\/PD-L1 Blockade","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib4","first-page":"4100","article-title":"Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma","volume":"39","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2024.114086_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","article-title":"A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion","volume":"18","author":"Jin","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celrep.2024.114086_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T\u00a0cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114086_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2024.114086_bib8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114086_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109285","article-title":"Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer","volume":"35","author":"Pingili","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","volume":"4","author":"Mansurov","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2024.114086_bib11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/1078-0432.CCR-20-3944","article-title":"Intratumoral Plasmid IL12 Expands CD8(+) T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy","volume":"27","author":"Telli","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.114086_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41591-021-01462-y","article-title":"Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial","volume":"27","author":"Creelan","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.114086_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112090","article-title":"Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110021","article-title":"Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade","volume":"37","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41551-021-00831-9","article-title":"Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity","volume":"6","author":"Agarwal","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2024.114086_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8075","article-title":"Cell surface\u2013tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T\u00a0cell therapy","volume":"8","author":"Jones","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.114086_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6899","article-title":"A tumor-specific pro-IL-12 activates preexisting cytotoxic T\u00a0cells to control established tumors","volume":"7","author":"Xue","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.celrep.2019.08.095","article-title":"Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment","volume":"29","author":"Mills","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41551-022-00888-0","article-title":"Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker","volume":"6","author":"Mansurov","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2024.114086_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s43018-019-0003-0","article-title":"PAK4 inhibition improves PD-1 blockade immunotherapy","volume":"1","author":"Abril-Rodriguez","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2024.114086_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.107500","article-title":"Biotechnological potential and applications of microbial consortia","volume":"40","author":"Qian","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.celrep.2024.114086_bib22","doi-asserted-by":"crossref","first-page":"e00621-17","DOI":"10.1128\/mBio.00621-17","article-title":"Complete Biosynthesis of Anthocyanins Using E.\u00a0coli Polycultures","volume":"8","author":"Jones","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2024.114086_bib23","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41467-022-31932-x","article-title":"Spatiotemporal control of engineered bacteria to express interferon-\u03b3 by focused ultrasound for tumor immunotherapy","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114086_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc9436","article-title":"Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity","volume":"9","author":"Savage","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.114086_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","article-title":"Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy","volume":"13","author":"He","year":"2019","journal-title":"J.\u00a0Biol. Eng."},{"key":"10.1016\/j.celrep.2024.114086_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/1751-7915.13523","article-title":"Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy","volume":"13","author":"Yu","year":"2020","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.celrep.2024.114086_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114086_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.114086_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114296","article-title":"Progress of engineered bacteria for tumor therapy","volume":"185","author":"Fan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.celrep.2024.114086_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114086_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114086_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017925118","article-title":"The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114086_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2024.114086_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","article-title":"Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.celrep.2024.114086_bib35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/pharmaceutics13081226","article-title":"Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy","volume":"13","author":"Liu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.celrep.2024.114086_bib36","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1002\/adma.201506312","article-title":"Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celrep.2024.114086_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2024.114086_bib38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41565-021-00972-7","article-title":"T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy","volume":"16","author":"Zhai","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celrep.2024.114086_bib39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-\u03b3 from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer","volume":"112","author":"Abiko","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2024.114086_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221096219","article-title":"Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle","volume":"14","author":"Starzer","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.celrep.2024.114086_bib41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-022-01134-z","article-title":"Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles","volume":"17","author":"Li","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celrep.2024.114086_bib42","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/2159-8290.CD-20-1209","article-title":"Development of Immunotherapy Combination Strategies in Cancer","volume":"11","author":"Yap","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2024.114086_bib43","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.cell.2015.10.054","article-title":"SnapShot: T Cell Exhaustion","volume":"163","author":"Pauken","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.114086_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T\u00a0cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T\u00a0cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2024.114086_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T\u00a0cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-3083.2009.02281.x","article-title":"CD25 Blockade protects T Cells from Activation-induced Cell Death (AICD) via Maintenance of TOSO Expression","volume":"70","author":"Richter","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.188.7.1369","article-title":"The interleukin 2 receptor alpha chain\/CD25 promoter is a target for nuclear factor of activated T\u00a0cells","volume":"188","author":"Schuh","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.114086_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T\u00a0cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib50","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41590-020-00815-y","article-title":"Two parallel worlds of memory T\u00a0cells","volume":"21","author":"Chu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114086_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm1032","article-title":"Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors","volume":"8","author":"Nash","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.114086_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4968","article-title":"Preexisting tumor-resident T\u00a0cells with cytotoxic potential associate with response to neoadjuvant anti\u2013PD-1 in head and neck cancer","volume":"8","author":"Oliveira","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.114086_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109071","article-title":"Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy","volume":"35","author":"DeVito","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib56","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.celrep.2019.07.059","article-title":"Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma","volume":"28","author":"Burrack","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112693","article-title":"Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2","volume":"42","author":"Wu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.114086_bib58","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/acssynbio.6b00233","article-title":"Characterization of Endogenous and Reduced Promoters for Oxygen-Limited Processes Using Escherichia coli","volume":"6","author":"Lara","year":"2017","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.celrep.2024.114086_bib59","doi-asserted-by":"crossref","first-page":"10013","DOI":"10.1007\/s00253-014-6059-y","article-title":"Effects of cascaded vgb promoters on poly(hydroxybutyrate) (PHB) synthesis by recombinant Escherichia coli grown micro-aerobically","volume":"98","author":"Wu","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.celrep.2024.114086_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10351","article-title":"Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP-1 and modulating gut microbiota","volume":"8","author":"Wu","year":"2023","journal-title":"Bioeng. Transl. Med."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724004145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724004145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:54:42Z","timestamp":1762602882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724004145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2211124724004145"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114086","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1\/IL-12 engineered probiotics","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114086"}}